Marco Bertucci Zoccali, MD
Colon & Rectal Surgery · Chicago, ILNPI 1033537659
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Axonics, Inc. at 26.9% of the total.
Across 75 payments — averaging $132.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$3K
- Intuitive Surgical$2K
- Davol Inc.$2K
- BD$2K
- Medtronic$1K
- Polynovo North America LLC$135
- plus $643 from 10 others
Across 6 payments — averaging $6625.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$40K
What the payments were for
- Consulting fees$1,88619%
- Travel & lodging$3,70337%
- Food & beverage$3,32734%
- Education$1,00010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 15 | $2,663 |
| Intuitive Surgical | 9 | $2,069 |
| Davol Inc. | 10 | $1,775 |
| BD | 9 | $1,623 |
| Medtronic | 7 | $1,008 |
| Polynovo North America LLC | 1 | $135 |
| Johnson & Johnson | 5 | $129 |
| Boston Scientific | 1 | $123 |
| Daiichi Sankyo Inc. | 4 | $87 |
| Integra Lifesciences Corporation | 2 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Acell, Inc. | 2 | $50 |
| Merck | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$2,118
- Da Vinci Surgical System$1,922
- Phasix Mesh$716
- INTERSTIM$485
- Bulkamid$286
- Novosorb BTM$135
- RESOLUTION CLIP$123
How this compares
$9,916 in reported general payments places this provider in the 75th percentile of 79 colon & rectal surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 37 | $467 |
| Neomycin Sulfate | 20 | $96 |
| Metronidazole | 22 | $23 |
| Gabapentin | 18 | $17 |
| Tramadol Hcl | 13 | $16 |
| Oxycodone Hcl | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Chicago
- Marc SingerChicago$201K
- Francisco QuinterosChicago$119K
- Konstantin UmanskiyChicago$30K
- Vitaliy PoylinChicago$26K
- Neil HymanChicago$20K
- Amy HalversonChicago$19K
- Gerald GanttChicago$16K
- Jacqueline HarrisonChicago$15K
- Scott StrongChicago$12K
- Steven StrykerChicago$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.